Seminar to focus on clean technologies

Technologies like nanotechnology, biomaterials and microfluidics can play a powerful role in reducing the impact of industrial activity on the environment, while opening new markets for Alberta-developed products and services.

Following Alberta Premier Ed Stelmach's September 21 announcement of a collaborative agreement on research in energy and the environment with Rice University of Texas, more than 40 Alberta technology companies are gathering in Edmonton for the ACAMP's Cleantech Seminar on September 28 to exchange knowledge on their clean technology initiatives.

"As well as being North America's leading energy producer, Alberta is also becoming known for innovative, technology-driven products that make the production and the use of energy, and other resources, more efficient," said Ken Brizel, CEO of ACAMP. "This can help reduce greenhouse gas emissions, reduce industrial water usage and more."

"These technologies also make our industries more competitive and result in clean technology products and services we can sell worldwide," added Brizel.

In addition to clean technology solutions, the seminar features discussions by venture capitalists on moving ideas from the laboratory to the marketplace and the various ways to secure investment for entrepreneurs and start-up companies. Future ACAMP seminars will cover MNT (Micro Nano Technologies) for the health & medical, traditional energy and agriculture & forestry industries.

ACAMP is a not for profit organization that provides specialized technical and business services. ACAMP clients have access to world-class equipment, facilities, expertise and a network of organizations to support the development and manufacturing of micro and nanotechnology based systems and advanced materials for applications worldwide. ACAMP helps companies bridge the gap between first prototype and profitable product sales. ACAMP's funding comes from Alberta Advanced Education & Technology, Western Economic Diversification Canada and Industry. Funding for the ACAMP seminar series is provided by the National Research Council's Industrial Research Assistance Program.

Source:

ACAMP

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Research suggests no need for yellow fever vaccine booster after initial dose